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ABSTRACT
The phenomenon o f NIVIR plays an important role in a number o f different 
scientific and medical fields. Nuclear magnetic resonance has the ability to detect 
changes in tumour, and cell metabolism caused by both chemotherapy and radiation 
therapy treatments. This project determined the feasibility o f NMR spectroscopy for 
quantifying the effect of radiation therapy on the cellular metabolite levels o f the MCF-7 
cancer cell line. The metabolites were extracted using a ffeeze-thaw procedure developed 
for this study, and analyzed by NATR spectroscopy. Phosphorous spectra were 
normalized to the inorganic phosphate peak height, and relative peak height ratios were 
calculated for all phosphorous metabolites present. The standard deviations found for 
peak height ratios were determined by performing a control reproducibility study. It was 
found that the reproducibility o f intra-batch samples was much higher than that of inter­
batch samples. The percent error values for intra-batch samples ranged from 2.53 % to 
7.98 % tliroughout the different relative metabolite ratios, and for inter-batch samples, the 
values ranged from 38.61 % to 49.90 %. The post-irradiation times o f 2, 24 and 48 hrs 
were chosen, and the time o f 48 hrs was determined to yield the greatest quantitative 
change. Considering this, a range o f doses (4 to 12Gy) was examined at 48 hrs post­
irradiation. Through the qualitative examination of the peak ratios for all o f the 
phosphorous metabolites found in MCF-7 extracts, it was found that a direct correlation 
exists between the amount o f irradiation delivered, and the changes in metabolite 
intensities for the MCF-7 cell line. Therefore, based on these preliminary results, it has 
been shown that ^^P NMR can be used to monitor the effects of radiation therapy, and 
potentially, can be used to quantify a dose-response relationship.
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1.0 INTRODUCTION:
1.1 Cancer Overview
The Greek physician Hippocrates described cancer as a crablike disease that 
spreads throughout the body, eventually cutting off life [1], Today, the term cancer refers 
to a group o f more than 100 different diseases characterized by uncontrolled growth and 
spread of abnormal cells [2], Cancer, a disease that has no limitations, attacks every race, 
age, and sex, and is global. It is estimated that about 134,000 Canadians develop some 
type o f cancer annually [3], and approximately 1,368,030 Americans will be diagnosed in 
2004 [2]. For newly diagnosed cases, only about half of the treatments will be 
successful, resulting in a very high morality rate. The United Kingdom currently 
attributes 1 in every 5 deaths to cancer [4]. Approximately 69,500 Canadians are 
expected to die o f cancer in 2005, which equates to more than 1,300 people a week [3]. 




The tenn chemotherapy literally means a method of treating a disease using drugs 
or medications. Cancer chemotherapy is the use o f cytotoxic drugs, also known as 
anticancer or cell-poisoning drugs, to treat cancer. The use o f chemotherapy drugs dates 
at least as far back in history as the 17^ and 18’* centuries, when belladonna, antimony 
and arsenic were employed to treat cancer [4]. Currently, there are more than 50 different 
drugs used for chemotherapy. Cytotoxic drugs act by interfering with the process o f cell 
division and therefore, are most effective on rapidly dividing cells. Cancer cells divide
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much more rapidly than normal cells, which makes chemotherapy a successful way o f 
treating cancer. Unfortunately, normal cells can also be damaged. Therefore, a careful 
balance between toxicity to the tumor and toxicity to the patient’s normal tissues has to 
be maintained.
1.2.2 Radiation Therapy Overview
Radiation therapy, also known as radiotherapy and x-ray therapy, is defined as the 
use o f ionizing radiation to kill cancer cells and shrink tumors [5]. The first patient cured 
by radiation therapy was reported in 1899, and in 1922, at the International Congress of 
Oncology in Paris [6], the medical discipline o f clinical radiation therapy began. In the 
last two decades, there has been a large growth in the knowledge of radiation physics, 
radiation biology, and clinical treatment planning, allowing for considerable 
advancements in the treatment o f cancer.
Radiobiology is the scientific study of the effects o f ionizing radiation on cells 
and tissues [4]. Radiation is particularly lethal to cells during mitosis [4], and can result 
in cell death or loss of reproductive capacity. The exact identity o f the vital structures, or 
critical targets, that must be damaged in this mechanism is still unknown [7]. However, it 
is generally accepted that the specific target o f radiation damage is the deoxyribonucleic 
acid (DNA) molecule that is contained within the chromosomes o f the cell’s nucleus. 
When radiation is absorbed in biological material, there is a possibility that it will interact 
directly with the critical targets in the cell. Radiation has both direct and indirect effects 
at the molecular level [7], A direct action o f radiation occurs when the atoms of the target 
become ionized or excited, which initiates a chain o f events that leads to a biological 
change. An indirect action of radiation results when the radiation may interact with other
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atoms or molecules in the cell to produce free radicals that are able to diffuse far enough 
to reach and damage critical targets. Indirect action damage is more predominant in 
radiation therapy. For example, a water molecule may become ionized upon interaction 
with a photon (x-rays or y -rays) or a charged particle (electron or proton). The ion that is 
formed has an extremely short lifetime (~ 10''" s), and the result of its decay is a free 
radical with no charge. The radical can react with another water molecule to form a 
highly reactive hydroxyl radical OH that can diffuse a short distance to reach a critical 
target in a cell. This hydroxyl radical is estimated to cause two thirds o f the x-ray damage 
to DNA in mammalian cells [7],
For any given area that is being treated with radiation therapy, both cancer cells 
and normal cells will be injured or destroyed. Therefore, as in the case o f chemotherapy, 
radiation therapy relies on the fact that most normal cells can recover from the effects of 
radiation and regain function more quickly than cancer cells. A careful balance has to  be 
maintained between the toxicity delivered to the tumor and that delivered to the patient’s 
normal tissues. The cellular damage resulting from these treatments can be monitored by 
Nuclear Magnetic Resonance (NMR) spectroscopy.
1.3 NMR Spectroscopy Overview
Nuclear Magnetic Resonance spectroscopy detects transitions in the magnetic 
energy of atomic nuclei when they are placed in a magnetic field and irradiated with 
radio waves. This phenomenon occurs only for atomic nuclei with a non-zero spin 
quantum number, i.e., those which posses an odd mass, odd atomic number or both. The 
sensitivity of the NMR experiment depends on two principle factors: the isotopic 
abundance of the NMR-active nucleus, and its magnetogyric ratio (y). The latter (y) is a
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constant that depends on the ratio o f angular precession frequency to the applied 
magnetic field strength, [8], Since each particular NMR-active nucleus has a
different charge and mass, each has a characteristic value of y. Hence, the larger the 
magnetogyric ratio for a particular nucleus, the higher the sensitivity of that nucleus in a 
given NMR experiment. There are a number o f different NMR active nuclei that exist, 
and each has a unique resonance frequency at a given applied magnetic field strength. 
Therefore, in a given NMR experiment, set at a specific frequency, only the resonance 
signals from a single isotope will be detected.
Even for a given nucleus, not all of the nuclei resonate at the same frequency. 
Each chemically distinct nucleus present in a sample has a particular resonance 
associated with it, e.g. Ethanol (CH3CH2OH) yields three 'H  signals. Therefore, each 
nucleus has a distinct resonance, and these resonance peaks are separated by a chemical 
shift that is indicated by the ppm value given to each. This separation exists because of 
the different electronic environments that surround each unique nucleus. These 
surrounding electrons create a distinct chemical environment, which gives rise to a 
predictable and measurable difference in assigned chemical shift values. The number of 
surrounding electrons, the presence of aromatic rings, and the presence o f electronegative 
moieties can all affect a given chemical environment in known ways.
An important feature o f NMR spectra is that the total integrated area o f a 
particular resonance signal is directly proportional to the concentration of the particular 
nuclei that gave rise to it. Therefore, relative concentrations for a given sample can be 
determined. With a number o f different NMR active nuclei available, each varying in 
sensitivity and natural abundance, the choice o f a particular nucleus is very important.
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The insensitivity o f NMR spectroscopy is the major disadvantage o f this instrument 
relative to other analytical tools. For a more detailed overview of NMR principles, one 
can refer to the book Nuclear Magnetic Resonance Spectroscopy by Frank A. Bovey [9],
1.3.1 Cancer Research via NMR Spectroscopy
Nuclear Magnetic Resonance (NMR) has been established as a noninvasive 
method for studying the metabolism of intact cells, tissues, and living organisms. 
Experiments are now being conducted to explore biosynthetic pathways, cellular 
metabolic activity, and intracellular reaction rates [10]. The bulk of current NMR cancer 
research focuses on and 'FI spectroscopy. Hydrogen-1 is the most NMR sensitive 
stable isotope in terms of both its high gyromagnetic ratio and high natural abundance. 
Phosphorous-31 has a natural abundance o f 100 %, and its relative sensitivity compared 
to that o f 'H  is only 6.6 x 10'" [10]. Therefore, the corresponding order of magnitude 
detection limits are 0.5 mM for and 0.1 mM for 'H  NMR [10]. For cellular 
metabolism, one o f the most important advantages o f  ̂ 'P NIVIR is that it is capable o f 
detecting metabolites, such as adenosine triphosphate (ATP), phosphocreatine (PCr), and 
inorganic phosphate (P i), which play a key role in tissue metabolism. When using liquid- 
phase NMR, it is important to note that highly immobilized compounds give rise to 
signals that are often too broad to observe and therefore, are NAIR-invisible [11]. For 
example, phospholipids incorporated in cell membranes are NMR-invisible. If the 
membrane is broken down, this could result in the smaller phosphodiesters, and 
phosphomonoesters becoming NMR-visible. NMR-invisible molecules can yield 
relatively uncomplicated spectra when analyzing complex mixtures such as living cells 
and tissues.
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1.3.2 Cellular Metabolites
The knowledge o f how tissues of a cancerous origin differ from normal tissues 
may help in understanding the underlying mechanisms of cancer. Phosphorus-31 NMR 
studies, examining the distribution of metabolites within human breast tumours [12], and 
the variance in malignant and benign [13] tissue profiles from normal [14, 15], have been 
shown in the literature [13-15]. Proton NMR studies of the variance between breast 
tumours and adjacent non-involved breast tissue have also been reported [12, 16].
Due to the complex nature of both tissues and cells, a tremendous number of 
metabolites are to be expected. However, NMR spectroscopy can only detect a small 
number o f metabolites, which occur naturally in large enough concentration. Expectedly, 
'H  NMR yields the highest number o f metabolites due to its natural abundance and 
sensitivity. However, there has been extensive work with ^'P, '^C, "^Na, and 
nuclei as well. The particular NMR experiment ('H , ^'P, or '^C) that is chosen selects the 
particular metabolites that can be detected, and the type o f tissue or cell being examined 
has a direct effect on which metabolites are most abundant in the sample. Each detected 
metabolite can reveal information about a specific biochemical pathway or can be used in 
combination to reveal a better picture of what is going on within the cell.
In this summary, the metabolites that most commonly occur in ^'P and 'H  NMR 
experiments will be discussed. Some of the most commonly observed proton metabolites 
are N-acetyl aspartate (NAA), creatine (Cr)/phosphocreatine (PCr), choline 
(Ch)/phosphocholine (PC), lactate, and a variety o f sugars and amino acids. The NAA 
metabolite is most commonly observed in *H spectra o f normal brain tissue, and its exact 
function is largely unknown [17]. A large number o f normal tissues contain creatine and
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phosphoryiaîed creatine. Although the exact role o f PCr remains under investigation, 
these metabolites play a major role in the energy metabolism of tissues. They act as an 
energy buffer by retaining constant ATP levels through the creatine kinase reaction and 
as an energy shuttle by diffusing from energy producing to energy utilizing sites [17].
The metabolite o f choline is an essential nutrient and is metabolized in three distinct 
pathways: Kennedy Pathway, oxidative pathway, and acétylation pathway [18]. The last 
'H  metabolite that will be discussed is lactate. Lactate has received a lot of attention 
because it is a metabolically important marker of tissue ischemia and hypoxia. The 
formation o f lactate is usually related to a decrease in high-energy phosphates, which 
makes lactate a good candidate for complimentary 'H  and ^'P experiments.
Previously, it has been shown that certain metabolites can be detected by using 
different nuclei NMR experiments. Phosphorous-31 NMR spectra share some metabolites 
with proton spectra. There are many other metabolites that appear in ^'P spectra. A ^'P 
spectrum is basically composed o f two major regions: the phosphorylated metabolites 
related to membranes, and high-energy metabolites [19]. There are two types of 
phosphorylated metabolites related to membranes that are detected [20, 21]. The first type 
o f phospholipid-related peaks is due primarily to phosphomonoester (PME), which 
consists of the up-held component PC [19] and the downfield component 
phosphoethanolamine (PE) [19]. These metabolites are synthesized by the enzymatic 
activity of ethanolamine and choline kinases that catalyze the first step o f phospholipid 
biosynthesis in vivo. The second type o f phospholipid-related peaks consists of 
phosphodiester (PDE) peaks. This region is due to GPC and GPE, which are the 
respective products o f phosphatidylethanolamine and phosphatidylcholine catabolism.
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The high-energy metabolite region [19] o f a spectrum usually consists of PCr, ATP,
Pi, and Uridine diphosphorous (UDP) sugars. Adenosine triphosphate (ATP) is a source 
o f free energy for biosynthetic reactions that occur in a cellular system. There are two 
thermodynamically favourable reactions that ATP can undergo. The first is phosphoryl 
transfer to form ADP and glucose-6-phosphate (G6P), and the second reaction is 
hydrolysis of ATP to form ADP and Pi [22]. Therefore, the decrease or increase in the 
level o f ATP can have a direct effect on the concentration o f metabolites present in the 
high-energy region of a ^'P spectrum.
At present, there are no in vitro or in vivo biological diagnostic tests that can 
predict the reaction of an individual tumour to chemotherapy and radiation therapy. It has 
been reported [20] that NMR spectroscopy can be used to detect the alterations in cellular 
metabolite levels following these treatments. Therefore, it may be possible to employ this 
method to optimize the therapeutic protocol by testing the effects o f various therapeutic 
agents [23]. The research undertaken in tliis project examined the cellular metabolite 
levels present in the MCF-7 human breast cancer cell line, using 'H  and ^'P NMR 
spectroscopy. These two types o f spectroscopy were used to provide a complimentary 
view of the metabolites present in this cell line.
1.4 Chemotherapy Summary
The ability o f NMR to detect changes in tumour metabolism and effects of 
treatment has been established for many years [20]. However, the use o f NMR as a 
diagnostic tool and aid to therapy is still in the preliminary stages [24]. A preliminary ^'P 
NMR study [25] reported a chemotherapeutic response to Adriamycin in the metabolism 
of murine mammary 16/C adenocarcinoma. The results confirmed that quantitative
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differences exist between the levels o f specific metabolites in different tumours before 
and after treatment using antineoplastic agents [25]. Another study [26] examined the 
effects o f tamoxifen, a nonsteroidal antiestrogenic agent, on MCF-7 human breast cancer. 
With the use o f NMR spectroscopy, it was found that short-term tamoxifen treatment 
modified the content of the phosphate metabolites, increasing the ratio o f nucleoside 
triphosphate to inorganic phosphate [26]. These results provided new information 
regarding the response and the mechanism of action for tamoxifen.
Since the discovery of estrogen and progesterone receptors in breast cancer cells, 
a number of different research projects have been undertaken to study the potential 
metabolic and bioenergetic perturbations among estrogen-independent, antiestrogen 
sensitive, and antiestrogen resistant variants of the estrogen-dependent MCF-7 human 
breast cancer cell line [26-28]. One group used '̂P NMR to investigate the effects o f 17^- 
estraiol and tamoxifen on a series of novel MCF-7 cells that varied in their estrogen and 
antiestrogen responsiveness. The results of this study [27] showed that the estrogen 
treatment lacked consistency with respect to the significant spectral changes in any o f the 
cell lines. However, treatment with tamoxifen showed an increase o f 30-40% above the 
baseline for all '̂P spectral resonances in the estrogen-independent and -responsive cell 
lines. In another project [28], the effects o f antimitotic drugs on a number o f human 
breast cancer cell line variants were examined by '̂P NMR. These cell lines included 
cells that were at different stages o f progression from hormone-sensitive to -insensitive as 
well as metastatic phenotypes. The significant differences between the spectra for the 
different cell lines yielded a unique marker of the metabolic state for a given cell line.
The M B231 (human breast cancer) cell line was treated with a number o f antimicrotubule
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drugs; paclitaxel, nocodazole, vincristine, and colchicines This specific cell line was also 
treated with Adriamycin and methotrexate, which are non-antimicrotubule-active drugs.
It was shown that antimicrotubule drugs enhanced the concentration o f intracellular 
glycerophosphoiylcholine (GPC) (relative to P-ATP). This effect was not reported for the 
non-antimicrotubule-active drugs [28]. To confirm the origin o f the changes in GPC, a 
control experiment was performed. The spectra revealed that the increase in GPC was 
due to an increase in GPC content and not to a change in GPC relaxation times. This 
study demonstrated that ^'P NMR spectroscopy may be used as an identification tool for 
the various stages of tumour progression and for the prediction o f anticancer treatment 
success [28].
It remains difficult to predict precisely which patients will initially respond to a 
specific therapy. A contributing factor to this, known as drug resistance, is a major 
clinical problem in cancer chemotherapy [29]. This occurs when a tumour is resistant to a 
particular drug that is being used for treatment. Another phenomenon is pleiotropic drug 
resistance (PDR), otherwise known as multidrug-resistance (MDR); it is manifested as a 
resistance to a variety of drugs with different structures and different mechanisms o f 
action [29]. Two ^'P NMR studies [29-30] were undertaken to investigate the possible 
metabolic basis for PDR. For these studies, two types of cell lines were chosen. One was 
an established human breast cancer cell line (MCF-7), and the other was selected because 
o f  its PDR behaviour, plus its resistance to Adriamycin. The results showed that there 
were clear distinctions between ^'P spectra o f the WT (drug-sensitive) cell line and the 
ADR (drug-resistant) cell line. Another study [31] employed both ^'P and 'H  NIVIR 
spectroscopy to analyze drug-sensitive (WT) and multidrug-resistant (ADR) MCF-7
10
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human breast cancer cell lines. The '"P and 'H  NMR spectra showed differences between 
the WT and ADR cell lines. A quantitative comparison of the relative concentrations of 
the major metabolites and precursors for both types of nuclei was performed [31]. The 
concentrations of choline (Ch) and creatine (Cr) were calculated by subtracting their 
corresponding phosphorylated ^'P signal values from the values obtained from 'HNAIR 
spectra. The calculated choline levels for both types o f cell lines are very similar.
However, the calculated creatine levels show that ADR cells make more than twice as 
much creatine as WT cells which generate more precursors for ATP and ADP high- 
energy phosphorus compounds. The ability to discern the concentrations of choline and 
creatine provided information regarding the differences in the control o f energy and 
phospholipid metabolism in ADR (drug-resistant) cells compared to WT (drug-sensitive) 
cells.
A particular type o f tumour that has an inherently high resistance to conventional 
chemotherapy is pancreatic cancer [32]. The effects of the metabolic inhibitors on human 
pancreatic cancer cells using ^'P, 'H, and ^^Na NMR were evaluated in the literature [32]. 
It was found [32] that the metabolic inhibitor 2-deoxy-D-glucose (2-DG) had similar 
effects on pancreatic cancer cells as on multidrug-resistant MCF-7 cells, and its 
cytotoxicity was much higher in these cells than in the drug-sensitive cells. Another study 
[33] used NIVIR to detect the bioenergetic changes induced in Ehrlich ascites tumour cells 
by the metabolic inhibitor 2-DG. It was found that when 2-DG was administered along 
with 3-0-methyl-D-glucose (3-0-MG) or Photosan II, there was a reduction in energy 
status. The post-recovery was lower with the use o f the multi-drug treatment compared to 
the effects when either drug was administered separately. Therefore, since the metabolic
11
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depletion o f ATP is known to inhibit the post-irradiation DNA repair processes, it is 
possible that these drug combinations, used as adjuvants to tumour radiotherapy, could 
enhance the therapeutic efficacy,
A different approach toward the understanding o f drug-resistant tumours was 
reported in the literature [34], In this study [34], plasmalemmal pH-gradients in 
xenografts o f drug-sensitive and drug-resistant MCF-7 human breast carcinoma cells 
were measured by ''P  NIVIR. The use o f NMR to measure intracellular pH (pH ) is 
possible by examining the chemical shift of endogenous inorganic phosphate [35]. It is 
also possible to measure extracellular pH (pH ) by using exogenous 3- 
aminopropylphosphonate (3-APP) [36], It was found [34], for all cell lines, that the p H  
and pH  values decreased with increasing tumour growth. However, a p H -p H  gradient 
was found to increase with tumour size for the drug-resistant variants o f MCF-7 cells but 
not for tumours of the drug-sensitive cells. The results state that a large pH gradient could 
protect the cell from weak-base drugs such as anthracyclines and Vinca alkaloids, which 
have pKa values of 7.5 to 9.5. Therefore, the enhancement of the therapeutic efficacy of 
weak-base drugs, via metabolic manipulation o f the extracellular pH, could be a 
possibility.
It has been shown that '̂P and 'H  NMR have the ability to detect changes in the 
metabolite levels induced by chemotherapy treatment. However, there is very little 
information in the literature that quantifies the relationship between the changes in 
metabolites in direct relation to the dose o f chemotherapy delivered. Therefore, it is 
unclear whether the response o f the cellular metabolites can confirm the degree of 
effectiveness for a given chemotherapy treatment.
12
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1.5 Radiation Therapy Suinmai'y
Differences between the NMR spectra o f normal and tumour cells could lead to 
new methods of radiation treatment. These treatments would be directed toward 
differentially enhancing the manifestations o f radiation-induced damage in tumours and 
minimizing damage in normal tissues. This would ultimately improve the efficacy of 
tumour therapy [37]. In the literature, one group [37] used^'P NMR to study the effects 
of radiation treatment on Ehrlich ascites tumours, which were treated with 2-DG and 
Photosan-3. It was found that the combination o f these two drugs had the potential to be 
used as an adjuvant to tumour radiotherapy. The same conclusion was reported in an 
earlier study [33], which used the Ehrlich ascites cell line. Therefore, the results o f these 
studies [37] add to the validity o f these drugs potentially being used in therapeutic 
practices. In a different study [38], ^'P and 'H  NMR were employed to examine the 
effects o f brain tumour radiotherapy. The purpose of this study was to monitor the 
changes that occur in the human brain following fractionated clinical radiotherapy. This 
is important because external beam radiation treatment of brain tumours results in 
radiation exposure o f normal tissue that lies within the treatment area. This can cause 
delayed effects such as demyelination and radiation necrosis. The results of this study 
[38] suggest that any radiation-induced damage that may occur from brain tumour 
treatment is invisible to ^'P NMR spectroscopy. However, 'H  spectra did show post­
irradiation changes in the ratios of Cli/NAA, Cr/Ch, and NAA/Cr [42]. In a more recent 
study, it was confirmed that 'H  NMR could detect the metabolic effects of radiation 
treatment on brain tumours [39]. This study [39] specifically looked at monitoring the 
changes that occurred during post-surgical fractionated radiotherapy [39]. It was shown
13
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that in order to establish biological markers for radiation damage in the treatment o f brain 
tumours an analysis o f all visible metabolites, as opposed to the use of just specific ratios, 
is required [39]. Similarly, using an analysis of correlation between measured parameters, 
a NMR study [40] looked at the acute effects o f y-radiation on rat brain metabolism. 
This study reported changes in the relative levels o f brain phosphate metabolites and 
intracellular pH at selected times post-irradiation corresponding to a single dose o f 6.5 or 
300 Gy. Phosphorous spectra showed only minor changes post-irradiation. A new 
parameter called the Z-index was used for spectral analysis. The Z-index is a 
mathematical manipulation of the integral intensities o f each peak found in the ^'P 
spectra and includes the intracellular pH value. For each animal, these variables were 
normalized to the total NMR-visible phosphate content. The Z-index, a multi­
dimensional statistical analysis, has the ability to correlate changes in a number of 
parameters that characterize the system as a whole [40]. The results showed an increase 
in Z value one day after 300 Gy was administered and two days after a lower dose of 6.5 
Gy was used. Due to the fact that only minor changes were reported for integral values 
[40], the Z-index may be a more sensitive indicator o f an imbalance in brain energy 
metabolism.
As shown previously [29], a major clinical problem in chemotherapy is drug- 
resistance. Similarity, it has been reported repeatedly [41-45] that different types of 
tumours can display varying radioresistant and radiosensitive responses towards radiation 
treatment. In radiation therapy, tumour oxygen content is considered a strong biological 
modifier of ionizing radiation effects [46]. The absence o f oxygen is believed to interfere 
with the intracellular biochemical events following irradiation [4], and the degree of
14
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sensitization to oxygen is described by the oxygen enhancement ratio [4], The oxygen 
enhancement ratio is defined as the ratio of doses necessary to achieve the same 
biological effect in the presence or absence o f oxygen [4], Therefore, tumour hypoxia has 
been considered a major cause o f cellular necrosis and radiation failure [47 j. To explore 
this effect by using NMR, a study [48] o f the changes in spectra of irradiated 
radioresistant mammary carcinoma (MCa) and radiosensitive methylcholanthrene- 
induced fibrosarcoma (Meth-A) tumours was performed. These two tumour models were 
chosen because both differ in radiosensitivity due to their inherent oxygenation states.
The ^^P spectra showed differences in the metabolites of these two tumour models, 
particularly in the PCr/Pi ratio. It was concluded that the metabolic differences observed 
in this study were related to variations in tumour perfusion and energy metabolism. 
Nevertheless, this study indicates that it may be feasible to relate differences in the 
tumour radiosensitivity o f  ̂ ^P spectra obtained non-invasively. A more recent study [49] 
used ^'P NTVIR spectroscopy to examine the effects o f radiation treatment upon a hypoxic 
murine mammary carcinoma. The tumors were monitored over the course of nine days, 
starting prior to irradiation and continuing post-irradiation. The tumours were irradiated 
with a single dose of 0, 4, 8 , or 17 Gy, and the results were then combined with the 
results from a previous study [50] performed by the same research group, which used a 
single dose of 32 and 65 Gy on the same tumour model. The results showed changes in 
tumour metabolism post-irradiation that include a dose-dependent change in the relative 
amounts of phosphonionoesters, an increase in the PCr/Pi and NTP/Pi ratios, and an 
increase in one o f the PDE peak components, GPC, relative to (5-NTP (nucleotide 
triphosphate). This study reported that both dose and time post-irradiation have
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R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
significant effects on phosphorus metabolite analysis. However, the feasibility o f a dose- 
response relationship was confirmed in a different study [51]. This group used NIVIR 
spectroscopy to evaluate the effects o f radiation on L 1210 cells. The results indicated a 
relationship between the applied radiation dose and the measurement o f ATP 
concentration. This trend is not seen for all types o f cell lines or tumours. A study [52] of 
the effects of radiation on phosphorus metabolites in two well-established human 
squamous cell carcinoma (SCC) cell lines (SQ38 and SQ20B) [53, 54] was performed. 
These two cell lines are known to have different radio sensitivities. The results showed 
that statistically all measured metabolite levels (energy metabolites and membrane 
metabolites) had insignificant changes with respect to their controls. Therefore, one can 
see that further NMR studies are required in order to determine if this dose-dependent 
correlation can be utilized as a potential therapeutic tool.
A number o f  ̂ 'P NMR spectroscopy studies have explored the mechanism of 
radiation-induced damage by examining the gain and loss o f ATP signal intensities [51,
55, 56]. These intensities were determined by measuring the ATP ADP Pi phosphate 
signals. However, a number of studies [21, 57-62] have shown that the phospholipid 
turnover parameter is a possible biomarker for radiation-induced responses in both in vivo 
and in vitro experiments. A ^'P NMR study was undertaken [21] that examined the 
radiation response o f Ehrlich ascites tumour cells following a dose of 6  Gy. The 
reasoning for this study [2 1 ] was to identify possible biomarkers o f radiation response. 
The results showed a continuous decrease in the amount of PME and PDE up to 2 hours 
post-irradiation. In addition, the PC/GPC ratio in irradiated cells showed a large decrease, 
compared to the untreated cells, at the time interval of 3-7 hours post-irradiation. This
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further confirmed past reports [57, 58] that showed the PME peak as a sensitive indicator 
of post-irradiation tumour ceil response. In previous studies of Non-Hodgkin lymphoma 
[59] and murine mammary carcinoma NU-82 [60], it was reported that the PDE region 
has the most radiation sensitive metabolites, making this region a possible pathological 
marker in steady-state response. In a different ^'P NMR study [61], the effects of 
radiation on phospholipid-related peaks in mammary carcinoma tumour extractions were 
explored. It was reported [61] that 24 hours after a dose o f 32 Gy was delivered, there 
was a significant increase in the ratio of PE/PC, and the ratio of ethanolamine-containing 
to choline-containing phospholipid metabolites showed a large increase between 48 to 96 
hours post-irradiation. Similar results were seen in the spectra o f a single dose of 65 Gy.
It was concluded [61] that the post-irradiation response o f the lipids occurred more 
slowly when compared to the metabolites, and therefore, the changes in the phospholipids 
are secondary to the changes in the metabolites. It should also be noted that distinct 
changes in phospholipids became visible only 48 hours post-irradiation [61]. In another 
^^P NMR study, the post-irradiation effects on radiation-induced fibrosarcoma-1 (RlF-1) 
tumour model were examined over the course o f seven days [62]. The results showed that 
the two primaiy changes in ^'P NMR spectra are the increase in PME/PC and in 
GPC/NTP ratios that were reported to occur directly at the cellular level [62]. From these 
studies [57-62], it can be concluded that the phospholipid profiles o f tumour cells can 
represent a reliable and sensitive biomarker for the assessment and monitoring of 
radiation response. These studies [57-62] do not provide a quantitative method, which 
would allow the change in phospholipid metabolite profiles to be used as a tool to predict
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post-irradiation dose effects. Hence, there is only a distinct qualitative response in 
phospholipid metabolites post-irradiation for the examined tumour and cell types [57-62].
The accumulation of data formulated from the previous studies [37-64] has 
indicated that NMR has the ability to indirectly monitor induced changes in cellular 
metabolites. A study [65] that explores the possibility of using NMR to predict the 
optimum interval between fractionated irradiation doses has been reported. This study 
[65] reported changes in the metabolites o f murine mammary carcinoma (FM3A) cells in 
a fractionated experiment. The radiation was delivered using two fractions at a dose of 5 
Gy per fraction, and the radiation was given at 0, 1, 2, 3, and 6 -day intervals [65]. The 
mean P-ATP/P; and PCr/P; ratios on day two post-irradiation were significantly higher 
than the pre-irradiated levels. After day two, these ratios decreased sharply and returned 
to the initial ratio values on day three. The results showed that fractionated irradiation, 
with a 2-day interval, had more of an effect on P-ATP/Pj and PCr/ Pi peak ratios than 
other fractionated schedules. Assays were then performed on the irradiated samples to 
determine the growth fraction of the samples. It was found [65] that the maximum growth 
fraction occurred at two days post-irradiation, which coincided with the results for 
fractionation. It was concluded [65] that p-ATP/T; and PCr/ P, peak ratios could be a 
potential indicator for determining the fractionation schedule in radiation therapy.
The use o f 'H  NMR, in comparison to ^^P NMR, yields spectra that consist of 
more peaks, which are due to the increased sensitivity of the proton nuclei and the natural 
abundance of proton metabolites [10]. Through the use o f ' H  NMR [55, 63, 64], it has 
been shown that lactate could serve as a sensitive biomarker o f tumour response. An 
early study [55] that looked at Ehrlich ascites tumour cells, reported that changes in
18
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lactate production were found, with a marked increase occurring 24 hours post­
irradiation. These findings were further supported by another study [63] that detected a 
substantial decrease in the lactate/creatine and lactate/choline values in the D-54 MG cell 
line post-irradiation. More recently [64], the effects o f y-radiation on the lactate levels of 
EMT6  tumours were reported using 'H  NjVIR. This study monitored EMT6  tumours over 
the course o f two days. The first spectrum was taken pretreatment, and additional spectra 
were taken at 24 and 48 hours after irradiation doses o f 4, 10, or 2 0  Gy were 
administered. The results showed [64] a 21% decrease in the lactate level at 48 hours 
after an irradiation dose of 10 Gy, and a 40% decrease was observed at 48 hours after an 
irradiation dose of 20 Gy. These studies [55, 63, 64] showed that the largest change in 
proton spectra post-irradiation is the decrease in lactate resonance, which could be used 
as a biomarker in tumour response.
1.6 Cellular Metabolite Extraction Summary
Previous work [6 6 ] has indicated that the signal resolution in cellular extracts is 
increased compared to that of in vivo systems. This result is due to the increased mobility 
of metabolites in a non-viscous environment [67]. Another major factor contributing to 
the increase in signal resolution in cellular extracts is the ability to provide greater 
concentrations of cellular metabolites in the fixed volume used for NMR. Therefore, 
cellular extraction was used for this research in order to examine the cellular metabolite 
levels in their most NMR-sensitive state. A number o f different types o f cellular 
extraction procedures have been used in the preparation o f cells for NMR studies. Studies 
have shown that a Dual-Phase Extraction (DPE) [6 8 , 18] method has been developed. 
This method extracts both the water-soluble and lipid metabolites from the same sample
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at the same time. However, the two most widely used extraction methods are the 
Perchloric Acid Extract (PC A) method and Folch’s method o f extraction.
Folch's method is used for the extraction o f cellular lipid metabolites. Folch et a i 
[69] first proposed this method in 1957. More recently, Folch’s original method of 
extraction has been slightly modified for the extraction of cellular lipids in cell cultures 
[15, 70]. The first step in this procedure was to wash the cell culture plates with a saline 
solution at room temperature. The next step was to add ice-cold methanol to each plate, 
and then place the plates on ice for 5 to 10 minutes while a mbber policeman was used to 
scrape the cells into pools. At this point, two volumes of chloroform were added and 
mixed, followed by 0.6 volume of 0.1 M KCl. The samples were vigorously mixed and
left overnight at 4 °C in order to allow for phase separation. The lipids were obtained
from the bottom layer. The final step o f  this method o f extraction was to dissolve the 
lyophilized sample in the solvent of choice for the NMR experiment.
The PGA extraction method is used for the extraction o f water-soluble cellular 
metabolites. There are a number of different modified PGA extraction methods [71-74] 
available. All of these methods follow a general experiment scheme. The first step in the 
PGA extraction was to harvest the cells from the culture plates using a reagent such as a 
Trypsin-EDTA solution. Once the cells were collected and washed, they were subjected 
to ice-cold Perchloric acid (0.5 M) in a volume that is dependent upon the number o f 
cells initially used. Following the addition o f perchloric acid, the mixture was sonicated
for 5 minutes at a temperature o f 4 °C. The solution was neutralized, using 5M sodium
hydroxide, and then centrifuged to remove the potassium perchlorate precipitate. The 
supernatant was treated with Ghelex 100, and then the solution was adjusted to a pH of ~
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8. This solution was lyophilized and then stored at -20 °C or colder in order to prevent
hydrolysis. The final step in this method of extraction was to dissolve the lyophilized 
sample in the solvent of choice for the NMR experiment.
1.7 Thesis Objective
This research project performed a feasibility study to quantity the effect of 
radiation therapy on the cellular metabolite levels o f the MCF-7 cancer cell line. The 
effects of radiation therapy were examined by and F̂1 NMR spectroscopy. The most 
important step in this quantitative study was to establish the limitations in the 
reproducibility o f NMR spectra for a cellular system. Due to reported variations [15, 55, 
6 8 , 70] in NMR spectra o f cellular metabolites in various samples o f non-treated cells, it 
can be noted that a minimum deviation exists pre-irradiation. Flence, the deviation seen 
in the spectra o f non-treated cells must be minimized and quantified before the effects of 
irradiation on cellular metabolites can be quantified.
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2.0 EXPERIMENTAL:
2.1 Nuclear Magnetic Resonance Spectroscopy
All proton (^H) and phosphorous (^^P) nuclear magnetic spectra of MCF-7 cancer 
cells, a commercially available human breast cancer cell line, were acquired using a 
Variai! UNITY Inova 500 NMR spectrometer system. This spectrometer operates on a 
Sun Ultra 5 Workstation. Both proton and phosphorous nuclei were measured in a 5 mm
probe, which was set at a temperature o f 23°C and at operating frequency of 499.72 MHz











^H 1 .0  sec 9.2 psec 
90° spin-angle flip
1.67 sec 26, 6 6 8 8 , 0 0 0 1 0 0
31p
2 . 0  sec 9.5 psec 
90° spin-angle flip
1 .0  sec 16, 0 0 0 8 , 0 0 0 800
Table 1. Acquisition parameters used for ‘H and ” P spectra.
Proton spectra were acquired using the presaturation technique to suppress the 
residual water signal contained in the extracted samples. The saturation delay and 
saturation power were maximized in order to optimize the presaturation technique in the 
samples. Through trial and error, the values were set at 5.0 s for a saturation delay, and 
the saturation power was set to 22. The acquisition parameters listed in Table 1 yielded 
^H spectra with reasonable signal-to-noise (S/N) ratio in less than 15 min.
Phosphorous spectra were acquired using gated proton broadband decoupling to 
eliminate ‘H-'^'P NMR multiplets as well as nuclear Overhauser enhancement artifacts. 
Under these conditions, each spectral resonance corresponds to a distinct phosphorous
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spin site. The acquisition parameters yielded NMR spectra with reasonable S/N in 
less than 45 min (Table T). Phosphorous spectra were Fourier-transformed using 6  Hz 
exponential multiplication, phased, and referenced to internal inorganic phosphate peak 
(set to 1 .8  ppm).
2.2 Cell Culture
A human breast carcinoma cell line, known as MCF-7, was used for all cell 
extraction experiments. This cell line was cultured in tissue culture dishes (15 cm in 
diameter) using Dulbecco’s modified Eagle’s medium (DMEM), which is supplemented 
with 10% fetal bovine serum, 4500 mg glucose/L, L-glutamine, NaHCOü, streptomycin 
(100 pg/mL), amphotericin (0.25 pg/mL), and 60 units/mL of penicillin. The tissue
culture dishes were stored in an incubator at 37 °C under a 5% carbon dioxide/air
atmosphere.
2.3 Irradiation Procedure
The cell culture dishes, including control dishes, were removed from the 
incubator, and brought to the Siemens Oncor accelerator. A 20 x 20 electron applicator 
was fixed to the head of the accelerator, and the cells were placed on the table at 1 0 0  cm 
SSD (source to surface distance). The energy used was 6  MeV with approximately 2 mm 
build up. After the specified amount of irradiation was delivered to the cell dishes, they 
were immediately returned to the incubator along with the control dishes. At this point, 
the cell culture dishes remained in the incubator for a determined length o f time, post­
irradiation, and then underwent a freeze-thaw extraction procedure.
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2.4 Freeze-Thaw Extraction
The DMEM was removed for the ceil culture dishes (3 dishes per sample) and 
then the dishes were washed with phosphate buffer saline solution (PBS) at room 
temperature. The dishes were aspirated and a Trypsin-EDTA solution was added and left 
for 2-3 min until the cells visually detached from the culture dishes. This suspension, 
which contained the MCF-7 cells, was transferred into a 50 mL conical tube. The culture 
plates were washed with additional DMEM to collect any cells that might have been left 
behind, and this solution was then added to the conical tube. The conical tube was placed 
into a GS-GKR Beckman Centrifuge at room temperature for 5 continuous min at 11 GO 
rpm. The supernatant, which contained a mixture o f DMEM and Trypsin-EDTA, was 
aspirated, and the cells were washed with balanced salt solution (BSS) that contained no 
phosphorous. The conical tube was placed back into the centrifuge for 5 min. The 
supernatant was aspirated, and the cells were washed with BSS again. The conical tube 
was placed back into the centrifuge for 5 min. The supernatant was decanted, and the 
cells were re-suspended in deuterium oxide (D2O), which was transferred evenly into a 
number of 1 dram glass vials. These vials were placed into a SANYO ultra low freezer at
-84 °C for one hour, and then transported (~ 30 min.) to Lakehead University using a
Thermos flask containing dry ice. The vials were removed from the dry ice and placed on 
the bench top for 5 min without their caps (to prevent the vials from exploding). They 
were then re-capped and placed into a room temperature water bath for 15 min. The 
cellular suspension contained in each vial was transferred into a 1.5 mL Eppendorf 
microcentrifuge tube and sonicated on ice for 10 s using a 20 kHz, 350 W Branson Sonic 
Power probe sonicator with the output control set at 4. After centrifugation at 11,000 rpm
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for 2  min, the supernatants were decanted into glass-weighing bottles, and frozen in a 
liquid nitrogen/ethanol bath. The samples were transferred directly to a Labconco Freeze
Dry System and lyophilized at -30  °C and 250 mbar for 24 h. After the completion o f
freeze-drying, only one sample at a time was removed. The remaining samples were left
in the freeze dryer at a temperature of -30 °C to protect against hydrolysis. Each freeze-
dried sample was transferred to a 1.5 niL microcentrifuge tube and resuspended in 1 mL 
D2O containing 0.63 M MgCfr. Finally, the sample was sonicated on ice for 10 s and 
transferred to 5 mm diameter NMR tube. It was concluded that a 10 mm diameter tube 
was not optimal due to sample concentration requirements.
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3.0 RESULTS AND DISCUSSION:
3.1 Extraction Procedure
The first step in this research project was to determine which cell line would be 
used for metabolite analysis. Two possible cell lines were evaluated: a human breast 
cancer cell line ‘MCF-7’ and a human ovarian cancer cell line ‘OVCAR’. Whereas '^'P 
NMR spectra o f OVCAR are dominated by a single metabolite signal (Figure l.A), the 
MCF-7 cell line yielded a number o f  ̂ 'P metabolite signals (Figure l.B) and was thus 
chosen for further analysis.
A series o f changes in the handling of the cell samples were implemented in order 
to improve the reproducibility o f the control samples.
A )
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Figure 1. A, ^'P spectra o f intact cells for the OVCAR ceil line; B, ’'P spectra o f intact cells for the MCF-7 
cell line.
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These changes optimized parameters such as temporal stability, signal-to-noise ratio,
inter-batch reproducibility, and intra-batch reproducibility. The modifications to the cell 
handling and extraction procedures are presented here in chronological order. Once the 
MCF-7 cells were removed from their culture dishes, the new unstable environment 
conceded a slow onset of cellular death causing large variations in ^'P spectra. This 
existed even when the samples were acquired at a specific time post removal. Cellular 
fixation using both para-formaldehyde and ethanol was attempted [75]. Unfortunately, 
when the para-formaldehyde fixative was employed, the resulting ^'P spectra were 
dominated by the inorganic phosphate signal (Figure 2. A). When the ethanol fixative was 
used, the signal-to-noise (S/N) ratio was greatly decreased (Figure 2.B).
Instead, it was decided that the MCF-7 cells would be suspended in a number of 
different solvents. The solvents that were chosen are distilled de-ionized water 
(DDW)/25% D2O, balanced salt solution (BSS)/25% D2O, and 100 % D2O. The use of 
different solvents yielded poor spectral reproducibility. The solvents had varying effects 
on not only the S/N ratio in the ^^P spectra, but also on the relative peak heights of 
metabolite signals that were present (Figure 3). These results were attributed to the 
manner in which these solvents directly affected the MCF-7 cells in suspension. The BSS 
solvent keeps the cells intact, while a large number o f the cells suspended in DDW/25% 
D2O solvent are lyzed. This hypotonic solvent creates osmotic pressure due to the 
migration o f water into the MCF-7 cells, which causes the cells to rupture. This process 
releases the phosphorus metabolites into solution, resulting in a greater S/N ratio for ^^P 
spectra (Figure 3) due to the increased mobility these metabolites have in the less viscous 
environment. This has been well documented the literature [67],
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Figure 2. A. ~’’P spectra o f MCF-7 cells fixed using para-formaldehyde; B. '̂P spectra of MCF-7 cells fixed 
using ethanol.
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Figure 3. ’'P spectra o f MCF-7 cells suspended in different soh ents; DDW /25%  D :0  (Top), BSS/25%  
D ;'o (middle), and 100% D 2O (Bottom).
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At this point in the extraction procedure, the solvent of DDW/25% D 2O was 
chosen because o f its increase in S/N ratio. It has been reported [79] that the divalent 
metal ion assists in the stabilization of high-energy phosphate metabolites. 
Therefore, a number o f ATP control standards that contained varying concentrations of 
NigCli were prepared. It was found that the concentration (0.63 moI/L) of MgCli yielded 
the highest increase in the consistency between metabolite ratios. There was also a slight 
increase in the average percent error for all the relative metabolite peak ratios found in 
spectra (Table 2 and Table 3). The resonance signals were broadened for the 
magnesium samples, resulting in only three singlet peaks, which is in agreement with 
published results [77]. However, the loss in resolution was accepted for the gain in 
overall reproducibility. Therefore, this concentration of was added to the 














SD 0.01167 0.00149 0.00193 0.00487 0.00674 0.00674
Percent 0.146 0.179 0.278 0.328 0.326 0.435
Table 2. Standard deviations (SD) for NM R experiments (n=3) performed on a single ATP DDW control 
sample, and the percent difference compared to the average value o f  the four runs for each ratio. The four 




Table 3. Standard deviations (SD) for NM R experiments (n=3) performed on a single ATP DDW./Mg^" 
[0.63 M] control sample and the percent difference compared to the average v alue o f  the four runs for each 
ratio. The four spectra were acquired at the same times post-preparation as in Table 2.
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Nevertheless, the spectral differences were still too large and inconsistent for qualitative 
analysis. It was speculated that hydrolysis was still occurring due to the concentration of 
DDW present in the sample. An .ATP control was made using DiO (0.63 M MgCb) as the 
solvent. It was found that the switch to D?0 (0.63 M MgCb) had a positive effect on the 
control’s reproducibility (Table 3). This enhancement could be explained by the isotopic 
effect o f D2O on hydrolysis reactions. This solvent, compared to H 2O, would decrease the 
reaction rate of hydrolysis.
An advantage o f the D 2O (0.63 M MgCh) solvent was a large reduction in the 
NMR water resonance peak for this cellular suspension. With the use o f the presaturation 
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Figure 4. ^'P spectra o f MCF-7 cells suspended in D DW  Mg'" [0.63 M]/25% DiO. Each spectmm is from 
a different sample that underwent the identical extraction procedure.
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Table 4. Standard dev iations (SD) for NMR experiments (n=3) performed on a single ATP D ;0/M g"“ 
[0.63 M] control sample, and the percent difference compared to the average value o f  the four runs for each 
ratio. The four spectra were acquired at the same times post-preparation as in Table 2 and Table 3.
Unfortunately, the use of D%0 as a solvent limited the S/N ratio. To compensate, 
sonication was employed in order to lyze the cells further while suspended in the 
D2O/O.6 3  M MgCb solvent (provided in Figure 5). After a number of different 
experiments, it was determined that sonication yielded a non-reproducible decomposition 
o f high-energy metabolites or a non-reproducible degree o f lyzing (Figures 5 and 6 ).
A)
-1 0  -1 2 -16 -18
B)
■■[-' I ' T""'"
-10 - n .  -11 -16T
C)
Figure 5. P spectra that show variations due to different sonication procedures; A. output control was set 
to 7 and the sample was sonicated over five 10 s intervals: B, output control was set to 2 and the sample 
was sonicated over three 20 s intervals; C, output control was set to 6 and the sample was sonicated over 
four 10 s intervals.
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Subsequently, sonication could induce hydrogen exchange with the D?0 solvent to form 
the HOD peak that is shown to dominate most spectra; two examples o f this are 
displayed in Figure 6  (B and C). The sonication process was optimized for 
reproducibility, and relied on three variables: output control; length of sonication; and 
number o f sonication runs. Table 5 summarizes the experiments performed and the 
different sonication settings used for each. A qualitative comparison of the spectra 
indicated that the highest reproducibility could be achieved with an output setting o f 4 
and one application of 10 s (Figure 7). Centrifuging was attempted in order to remove the 
bulk of cellular debris, but the cellular suspension could not be separated. The 
disadvantage of this procedure is that samples contained a large amount of water. Hence, 
the pre-saturation method was not completely successful in suppressing the water 
resonance peak in ^H spectra (~ 7.2 ppm) (Figure 7.B).
A)
\j' L
11.0 10.5 10 .0  9 .5  9 .0  8.5 8.0
B)
11,0 10.5 10.0 9 .5  9 .0  8 5  8.0
C)
■1.5 4 .0  3.5
1 1 .0  10.5 10.0 7 .0  0.5 6 .0  5.5 5 .0  -1.5 4 .0  3.5 3 .0
Figure 6. 'H spectra that show variations due to different sonication procedures; A. output control was set 
to 7 and the sample was sonicated over five 10 s intervals; B, output control was set to 2 and the sample 
was sonicated over three 20 s intervals; C. output control was set to 6 and the sample was sonicated over 
four 10 s intervals.
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Output Control Duration,s Sonication Intervals
7 1 0 3
7 1 0 5
6 1 0 4
4 1 0 1
2 1 0 3
2 2 0 3
2 30 3
Table 5. Each row describes an experiment that was performed using an identical procedure that only 
varies with sonication parameters. A ll experiments were performed using D ;0/M g'"  as the solvent and 
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Figure 7. A. '̂P spectmm o f the optimized sonication procedure: B. ‘H spectrum (using presaturation) of 
the optimized sonication procedure.
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Due to hydrolysis reactions, the internal water from the ceils and the water contaminants 
contained within the D2O solvent can create instabilities for the metabolites o f the 
sample. To remove the water from the samples, a freeze dryer was used following the 
sonication step. The spectra resulting from the optimized sonication procedure, followed
by 24 h freeze dry at -30 °C, are shown in Figure 8 . An improvement in the S/N ratio was
desired before quantative analysis could be carried out. A number of different methods 
were attempted. The method that showed the greatest potential was “freeze-thawing” . In
this method, samples were pre-frozen at -84 °C, which reportedly [79] has no affect on
the cell’s viability. A freeze-thaw cycle was used because the literature [78] states that
the viability o f cells that undergo fast freezing (70 °C/min) and thawing is around <0 . 1%,
and this step was introduced as the first step in the extraction procedure.
A)
M
-4 - 6  -8  - W  -12  -11  -1 6  -18
11 .0  1 0 5  10.0 9.5 9 .0  8.5 8.0
Ml s in.
T.O 6 ,5  6 .0  .s.5 5 .0  4 .5  -1.0
Figure 8. A. spectrum o f an extract that undenvent freeze-drying following the previously detennined  
sonication procedure; B, ’H spectrum (using presaturation) o f an extract that underwent freeze-dry ing  
following the previously determined sonication procedure.
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A)
, / \  A,
B)
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Figure 9. A. ’'P spectrum o f an extract that underw ent the finalized (freeze-thaw) extraction procedure; B. 
'H spectmm (using presaturation) o f an extract that undenvent tire finalized (freeze-thaw) extraction 
procedure.
This technique was employed to cause further lyzing of the cells, and improved the 
separation between the supernatant and cellular debris. Thus, centrifuging was attempted. 
However, the separation that was achieved was still poor. Finally, it was decided to 
suspend the cells in D 2O that did not contain magnesium ions because it was observed 
that the magnesium ions caused coagulation. This permitted the samples to be 
successfully centrifuged after sonication. The addition of the freeze-thaw cycle and 
centrifuging techniques allowed for twice the amount of cells (four culture dishes) per 
sample (-16.0 x 10^). This increase in cell concentration had a direct effect on the S/N 
ratio shown in the spectra o f Figure 9.
3,2 Peak Identification
Phosphorous spectra for freeze-thaw extracts displayed seven distinct metabolite 
resonance peaks. These metabolite peaks were categorized into two groups: the low-
35
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energy phosphates (LEP) [61] that were detected in the range of 0.0 to 4.0 ppm (Figure
10), and the high-energy phosphates (HEP) [61] that were detected in the range o f-1 0  to 
-14 ppm (Figure 11) An experiment studying the phosphorous metabolites of one extract 
over a 22 h time period was performed, and a spectrum was recorded every hour. The 
results from this experiment are shown in Figure 12. The identity of the inorganic peak 
(P i) peak was determined because the resonance peak at 1.8 ppm increased in intensity as 
time passed (cellular death increased) [25, 60]. All o f the other peaks decreased in 
intensity (Figure 12). Each of the LEP peaks was assigned by comparison with known 
chemical shifts of phosphorous metabolites (Table 6 ) [17, 31]. However, chemical shifts 
for HEP metabolites could not be found in literature. The literature only lists metabolites 
found in previously reported extraction procedures, not the method of freeze-thaw 
extraction that was developed in this project. Hence, different extraction procedures 
could yield different NMR-detectable metabolites [69-70] from those determined by 














Figure 10. ^'P Spectmm o f MCF-7 cells freeze-thaw extract displaying the LEP range.
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Figure 11. ^'P spectmm o f MCF-7 cells freeze-thaw extract display ing the HEP range.
Metabolite Literature Chemical Shift 
Values [19]
(Respect to PCr)







PE N/A 3.81 3.42
PC 3.12 3.51 3.10
Pi 1.82 2.51 1.66
GPE 0.44 0.6 0.53
GPC N/A 0 0
Table 6. The "'P NMR literature values f 19] are referenced to phosphocreatine (PCr) at 0.00 ppm at a 
pH=7.2, and are frilly com plexed with Mg'". The ’̂P NM R literature values [11] are referenced to 
glycerophosphocholine (GPC) at 0.49 ppm at a pH=7.4. ’'P NMR experimental values (complexed w ith 
Mg“T are referenced to GPC at 0.49 ppm at a pH=5.5. which had an effect on metabolite shifts compared 
to literature values [11, 19]. PE. phosphoetlianolamine; PC, phosphocholine; GPE, 
glycerophosphoethanolamine.
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Figure 12. P spectra o f  an MCF-7 control freeze-thaw extract, obtained at 1, 6, 9, and 22 h post the initial 
run. The P, was normalized to 1, and peak labeling was performed using the results from Table 6.
3.3 Metabolite Stabilization
The stability of the phosphorous metabolites was a parameter that needed to be optimized 
to achieve the best possible reproducibility for spectra. Two major modifications were 
made in the development o f the freeze-thaw extraction procedure. The first was the use of 
D2O as a solvent for the extracts, and the second was the addition o f the divalent ion of 
magnesium (Mg^^) to the D2O solvent. The effects o f these improvements are shown 
quantitatively in Table 7 and Table 8 , as percent difference values. These values report 
the changes in relative metabolite concentrations over time post-extraction. It can be 
concluded that the stability of phosphorous containing metabolites increased with the use 
ofDzO/Mg”  ̂as a solvent.
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Table 7. The control o f  this experiment is the initial P NMR spectrum that was acquired immediately 
following extraction. This experiment was performed using BSS as a solvent. Additionally, the extraction 
procedure used for tins experiment does not involve freeze-thawing or sonication. The resonance P, peak 
was normalized to one for analysis.
Ratio's Pi/PE Pi/PC Pi/GPE Pi/GPC Pi/HEPI Pi/HEP2
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Table 8. The control o f  this experiment is the initial P NNIR spectrum that was acquired immediately 
following extraction. This experiment was performed using D^O/Mg"" as a solvent. Additionally, the 
freeze-thaw extraction procedure was used for this experiment. The resonance P, peak was norm alized to 
one for analysis.
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The Pi peak for the corresponding ' *? spectra o f Table 7 and Table 8 increased in 
intensity as time passed. However, the rest o f the peaks decreased in intensity relative to 
the inorganic phosphate peak. The increase in P, is a result of the breakdown of organic 
phosphates caused by cellular death [60]. This increase in P, could led to the 
phosphorylation of other metabolites, such as choline, which could account for the large 
relative increase found for this metabolite in Table 7 and Table 8. It is apparent from the 
percent difference values reported in Table 8 that a number o f reactions are still occurring 
during the ~40 min acquiring time o f ̂ ^P NMR experiments. To avoid variance in 
metabolite levels, it is critical to keep the time between suspension of the cellular extracts 
and commencement of the NMR experiment the same for all samples. Hence, the number 
o f transients that can be performed for a ^^P NMR experiment is limited due to the 
lengthening of the acquisition time.
3.4 Reproducibility Studies
The freeze-thaw extracts were highly viscous. This resulted in line broadening of 
the resonance peaks for both ’H and ^^P spectra and caused a large amount o f peak 
overlapping in ’H spectra (Figure 9. B). Subsequently, a quantitative analysis o f the peak 
heights for metabolites in ^H spectra was deemed impractical for the present analysis. An 
analysis was performed on spectral peaks. It is important to note that a single extract 
sample required four cell culture dishes. Due to the expense o f materials such as culture 
dishes and growth medium as well as the large amount o f space the 24 culture plates 
occupy in the incubator, a limit o f six samples per experiment was set. For each 
experiment, all control samples underwent extraction simultaneously and were run one 
after another on the NMR the following day. All NMR experiments were conducted
40
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using identical parameters that included an acquisition temperature o f 23 °C. On any
given day, n spectra were obtained from separately prepared extraction samples. The
peak height reproducibility o f same day samples (intra-batch) is reported in Table 9 as the
average standard deviation. An unknown peak ( -  4.00 ppm) was detected in a small
number o f spectra that were obtained for non-irradiated (control) samples. Due to the
inconsistency o f this unknown peak, it was not included in this quantitative study. Peak
heights were measured, and the Pi resonance peak was normalized to one. There were six
combinations o f relative metabolite ratios determined. The standard deviation from the
mean peak height values for each day is shown in Table 9. The weighted average was
calculated for each peak ratio and is reported in Table 9.
SDw = 1/N  Si Hi SDj N =  Si lli (Weighted Average)
- i increments the day the experiments were acquired 
SD. = the average standard deviation values on ith day
The percent error o f the weighted average values for each peak ratio is listed in Table 10.
These values were used to determine the error bars for intra-batch samples.
DATE (n) Pi/PE Pi/PC PiiGPE Pi/GPC Pi/HEPI PI/HEP2
June 23 (2) 0.114 0.504 0.176 0.053 0.017 0.076
June 25 (2) 0.022 1.604 0.178 0.079 0.011 0.062
June 30 (2) 0.169 0.806 0.245 0.501 0.054 0.035
July 1 (2) 0.079 0661 CT127 0.003 0.106 0.076
Sept 16 (3) 0.659 0.817 0.516 0.116 (7213 0.204
Sept 21 (3) 0.146 O S # 0.289 0.041 0.135 0.145
Sept 22 (3) 0.096 1.331 0.063 0.123 0.077 0.116
Sept 28 (3) 0.137 1.295 0.368 0.085 0.005 0.159
Sept 29 (3) 0490 0.672 0.229 0.110 0194 0.267
Oct 14 (5) 0.076 0.862 0.209 0.173 0.118 0.169
Weighted Average SD 0.173 0.885 0.246 0.127 0.101 0.143
Table 9. The standard deviation from tire mean peak height ratio obtained for several independent 
measurements conducted on 10 different days. This value was weighted according to its value o f  n, in  order 
to achieve the weighted average value for each metabolite ratio. The experiment on September 16, 2004 
was the first one conducted after a two-month period where the cell line was not in use.
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Figure 13. ’'P spectra o f the LEP range o f five control samples obtained on October 14, 2004.
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Figure 14.  ̂ P spectra o f the HEP range o f  five control samples obtained on October 14, 2004.
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DATE (n) Pi/PE Pi/PC Pi/GPE Pi/GPC Pi/HEPI Pi/HEP2
June 23 (2) 2.772 4.986 2.549 1.104 0.697 2.630
June 25 (2) 0.778 15.065 2.962 2.009 0.310 1.335
June 30 (2) 2.688 (7178 3.068 7.031 2.241 1.273
July 1 (2) 1.298 6.256 2.354 0.097 3.062 2.016
Sept 16 (3) 8.721 7.214 6.340 2.661 4.742 3.703
Sept 21 (3) 4.860 5.133 6.425 1.799 4.581 4.137
Sept 22 (3) 2.492 10.976 0.953 3.074 2.239 2.709
Sept 28 (3) 2.083 9152 5.016 1.774 0.126 3.320
Sept 29 (3) 2.387 (7172 3.488 2.881 4 2 ^ 4,844
Oct 14 (5) 1.800 7.275 2.412 2.744 3.457 4.067
Weighted SD Error 3.061 77975 3.593 2.528 2.779 3.249
Table 10. The percent standard deviation from the mean peak height ratio is gh en. This value was 
weighted according to its value o f  n, in order to achieve the weighted average error value for each  
metabolite ratio. The percent error reports the dev iations in reproducibility for intra-batch control samples.
As an example, the five spectra that were acquired on October 14, 2004 are shown in 
Figure 13 and Figure 14, The corresponding statistics are listed in Tables 9 and 10. The 
average peak height ratio, average standard deviation and percent error for control 
samples that were acquired on different days are shown in Table 11. The values reported 
in Table 11 show quantitatively that inter-batch control samples have largely inconsistent 
reproducibility when compared to the intra-batch control samples (Tables 9 and 10). The 
lack of reproducibility is illustrated in Figures 15 and 16. These figures compare 
spectra that were acquired on three different experimental days using identical NAIR 
parameters and extraction procedures. The percent error o f the average values for each 
peak ratio, listed in Table 11, determined the error bars for inter-batch control samples. 
The results o f both reproducibility studies (Tables 10 and 11) cannot be effectively 
compared to the values found in the literature because there are no previously reported 
reproducibility studies. Literature provides some graphical (error bars) and tabulated 
standard deviation values [28, 49,61].
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DATE Pi/PE Pi/PC Pi/GPE Pi/GPC Pi/HEPI Pi/HEP2
June 23 4 y œ 10.116 6.896 4.773 2.439 2.885
June 25 2.786 10.647 5.995 3.936 3.495 4.632
June 30 6.306 8.777 7.993 7.131 =7413 2.736
July 1 6.077 10.566 5.415 3.502 3.458 3.792
Sept 16 7.552 11.318 6.145 4.341 4.487 5.513
Sept 21 3.013 6x81 4.492 2.258 2.944 3.504
Sept 22 3.868 12.128 6.572 4.009 3.446 4.269
Sept 28 6.582 14.151 7.346 4.795 4.047 4.794
Sept 29 7 970 10.887 6.558 3.810 <4519 5.521
Oct 14 4.215 11.842 8.649 6.306 3.422 4.149
Average 4.771 9.710 6.187 4.078 3.152 3.800
Average SD 2.381 3.770 2.389 1.890 1.259 1.563
Percent Error 49.899 38.820 38.612 46.344 39.952 41.122
Table 11. The average peak height ratio, average standard deviation, and percent error are given. The 
average SD is calculated from the mean peak height ratio. The percent error reports the deviations in  
reproducibility for inter-batch control samples.
However, these values are for specific doses o f irradiation and chemotherapy treatments 
that do not directly relate to the non-irradiated control samples in this study. Therefore, 
no reasonable quantitative comparisons can be drawn.
The increase in standard deviation and percent error values for inter-batch 
samples compared to intra-batch samples could be attributed to varying spin-lattice (Tj) 
relaxation times. This inconsistency o f Ti values would affect each particular metabolite 
signal in varying degrees, causing an overall change in the relative intensities of 
metabolite peak ratios found in NMR spectra. Inconsistencies for inter-batch samples 
could also be due to growth fraction variance. The term growth fraction refers to the 
proportion of proliferating cells in the cell cycle [4]. The cell cycle is composed o f four 
different phases: S (DNA synthesis), M (mitosis), and the gaps that precede and follow 
the S phase, G1 and G2 respectively [4]. It has been reported in literature [80] that 
variations of growth fractions can be found throughout cell culturing passages.
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Figure 15. spectra o f tlie LEP range for three control samples nm  on June 25, 2004. September 16, 
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Figure 16. ' P spectra of the HEP range for three control samples run on June 25, 2004. September 16. 
2004, and October 14, 2004.
45
R eproduced  witti perm ission of ttie copyrigfit owner. Furtfier reproduction profiibited witfiout perm ission.
Therefore, differences in the relative amounts o f metabolites found in inter-batch samples 
could be a major contributor to the variation in the reproducibility [52]. From the results 
found in this reproducibility study, it can be concluded that at least one non-irradiated 
(control) sample will be required for each irradiation run. This ensures that spectral 
reproducibility corresponds to the intra-batch standard deviation values for each 
experiment. Without a control sample, only relative radiation dose quantifications would 
be possible for each experiment.
3.5 Preliminary Irradiation Studies
The reproducibility study indicated that in order to minimize the standard 
deviations in irradiation experiments a control sample would be required for every 
experiment. The initial step for this preliminary study was to determine the delay time 
between irradiation and freeze-thaw extraction that displays the maximum degree of 
change in the relative metabolite intensities. For all irradiation experiments, the amount 
o f radiation delivered was within the possible therapeutic doses used for radiation 
therapy. Therefore, the results yielded useful information about therapeutic treatment 
effects. It has been reported [59] that there are two distinct stages of cellular repair that 
occur post-irradiation. Each stage can result in different relative metabolite intensity 
levels. The first stage is the transient stage. This occurs immediately following irradiation 
and lasts up to approximately 3 h post-irradiation [59], The second is the steady-state 
stage of repair, which reportedly lasts up to seven days post-irradiation [49, 61]. For this 
preliminary study, three different times post-irradiation were examined. These times 
covered both stages of repair. To explore the transient stage o f repair, a spectrum was 
acquired at a time of two hours post-irradiation (Figure 17).
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Figure 17. ^'P spectra o f MCF-7 cell extracts. A  non-irradiated ’control’ sample (red) is compared to a 
sample that received 8 Gy and was acquired two hours post-irradiation (green).





























Table 12. spectra were acquired for an irradiation sample two horns following irradiation and a control 
sample. The resonance P, peak was normalized to one for analysis. These values are indicators o f the 
degree o f  change that occurred in the relative metabolite levels due to radiation (8 Gy).
The irradiation sample in this experiment was given a dose of 8 Gy. The quantitative
changes that occurred between the irradiated spectrum and the control spectrum are
shown in Table 12. The P i/H E P I and Pi/E [E P2 ratio values increased for the irradiation
sample compared to the control. The largest change in ratio values occurred for the P i/P E
and P i/P C  ratios. To examine the steady-state stage of repair, the cells were examined 24
and 48 hours post-irradiation were examined.
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Figure 18. spectra o f  MCF-7 cell extracts. A non-irradiated 'controF sample (blue) is compared to a 
sample that received 6 Gy (red) and a sample that received 12 Gy (green). Both irradiated samples were 
acquired 24 hours post-irradiation.
For tliis experiment, the doses o f 6 Gy and 12 Gy were used for both 24 and 48 hours 
post-irradiation. The spectral changes for both doses at 24 hours post-irradiation are 
shown in Figure 18, and for 48 hours, the spectra are shown in Figure 19. The 
quantitative changes for 24 and 48 hours post-irradiation at the dose o f 6 Gy are reported 
in Table 13. The corresponding data for 12 Gy is reported in Table 14. It should be noted 
that the experimental procedure used for the steady state experiment had a variation 
compared to the procedure used in the transient experiment. The difference was that the 
control sample was re-plated on the day of irradiation because the density o f the cells was 
higher than optimal. This effect could also impact the irradiation samples. This higher 
than normal cell density could cause a decrease in cell proliferation and alter the growth 
fraction for this experiment.
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Figure 19. "‘P spectra o f MCF-7 cell extracts. A  control sample (blue) is compared to a sample tliat 
received 6 Gy (red) and a sample that received 12 Gy (green). Both irradiated samples were acquired 48 
hours post-irradiation.
Therefore, the degree of change present in post-irradiation spectra may have been altered 
due to a variation in the growth fraction o f the samples [8 1 ]. The P i/H E P I  and P i/H E P 2  
ratio values decreased for all o f the irradiation samples compared to the control, except 
for the 6 Gy dose at 2 4  hours post-irradiation. All of the metabolite ratios, except for 
P i/H E P I  and P i/H E P 2  ratios, showed a decrease in ratio values for irradiated samples 
compared to the control sample. The largest change in ratio values occurred at 4 8  hours 
post-irradiation. This change was in the phospholipid range, which consisted of G P E , 
G P C , P E , and P C  metabolites. These findings correspond to previously reported [5 7 -6 2 ]  
studies, which concluded that the phospholipid metabolite range was the most sensitive to 
radiation treatment. This preliminaiy study, which encompassed only a small number of 
times post-irradiation, indicated that 48  hrs post-irradiation yielded the most significant 
changes.
4 9
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Table 13. spectra were acquired for the irradiation samples at 24 and 48 hours post-irradiation. The 
resonance P, peak was normalized to one for analysis. These values are indicators o f the degree o f change 
that occurred in the relative metabolite levels due to radiation (6 Gy).
Ratio's Pi/PE Pi/PC Pi/GPE Pi/GPC Pi/HEPI Pi/HEPI
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Table 14. ” P spectra were acquired for the irradiation samples at 24 and 48 hours post-im diation. The 
resonance P, peak was normalized to one for analysis. These values are indicators of the degree o f change 
that occurred in the relative metabolite levels due to radiation (12 Gy).
Subsequently, a time delay o f 48 hours was chosen for a response versus dose
relationship study. Two different ranges of doses were used for this study. The first
consisted of 4, 6, 8 and 12 Gy. The second study used a dose range of 4.5, 5, 5.5, 6, and
8.5 Gy. Both experiments followed the same experimental procedures. The resultant
spectra for both irradiation experiments are shown in Figures 20-24. These spectra are
expanded in the two ranges of interest.
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Figure 20. ^'P spectra o f the LEP range for MCF-7 cell extracts. A control sample (dark yellow) is 
compared to samples that received 4 Gy (red), 6 Gy (green). 8 Gy (blue), and 12 Gy (Cyan). A ll o f the 
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Figure 21. ' P spectra of the HEP range for MCF-7 cell extracts. A  control sample (dark yellow) is 
compared to samples that received 4 Gy (red). 6 Gy (green). 8 Gy (blue), and 12 Gy (Cyan). A ll o f  the 
irradiated samples were acquired at 48 hours post-irradiation.
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Figure 22. ^'P spectra o f  the LEP range for MCF-7 cell extracts. A control sample (dark yellow) is 
compared to samples that received 4.5 Gy (red). 5 Gy (green), 5.5 Gy (blue), 6 Gy (Cyan), and 8.5 Gy 
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Figure 23. ""P spectra o f  the HEP range for MCF-7 cell extracts. A control sample (dark yellow) is 
compared to samples that received 4.5 Gy (red). 5 Gy (green), 5.5 Gy (blue), 6 Gy (Cyan), and 8.5 Gy 
(black). All of the irradiated samples were acquired at 48 hours post-irradiation.
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The qualitative changes in peak height ratios for the first dose range, which corresponds 
to Figures 20 and 21, are reported in Table 15. The relative qualitative changes for the 
second study, which corresponds to Figures 22 and 23, are reported in Table 16. In the 
results o f the first irradiation study, shown in Table 15, the value o f P / P E  and P i/G P E  
ratios decreased as the dose increased. However, in both irradiation studies, only these 
two metabolite ratios displayed any discernable pattern related to dose. The dose- 
dependent changes for each particular metabolite ratio were graphically examined. The 
control metabolite ratio was included for each experiment as the point of zero dose. A 
linear fit was performed on each set o f metabolite ratios (Figures 24- 29).
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Table 15. P spectra were acquired for the inudiation samples at 48 hours post-irradiation. These values 
are indicators o f  the degree o f  change that occurred in the relative metabolite levels due to the various 
radiation doses o f 4, 6. 8, and 12 Gv.
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T able 16. ’’P spectra were acquired for the irradiation samples at 48 hours post-irradiation. These values 
are indicators o f the degree o f change that occurred in the relative metabolite levels due to the various 
radiation doses o f  4.5, 5, 5.5, 6, and 8.5 Gy.
The metabolite ratios of Pj/PE (Figure 24), and Pi/GPC (Figure 27) showed a similar 
trend in behaviour for both irradiation experiments when plotted as a function of dose. 
With a limited number of points provided by these preliminary studies, there are a large 
number of graphical fits that could be made. However, characteristic patterns in the 
overall change in metabolite ratios are still present. There appears to be a scaling issue in 
the slope and y-intercept between runs from different days. This scaling issue is likely 
caused by a similar effect that leads to poor reproducibility in inter-batch control 
experiments.
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Figure 24. A linear fit o f  the metabolite ratio Pi/PE values for set one that consists o f 4, 6, 8, and 12 Gv 
doses, and set two consist o f 4.5, 5. 5.5, 6, and 8.5 Gy doses. An Error bar o f  1.47 percent was placed on 
the control metabolite ratio, which was obtained from Table 10. The correlation coefficients for set one are 
4.113 a n d -0 .001  with a p-value of 0.001. The correlation coefficients for set two are 6.952 an d -0 .0 0 6  
with a p-vahie o f 6.35 x 10''.
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Figure 25. A linear fit o f the metabolite ratio P/PC  values for set one that consists o f 4, 6. 8, and 12 Gy 
doses, and set two consist o f  4,5, 5, 5.5, 6, and 8.5 Gy doses. An Error bar o f  3.74 percent was placed on 
the control metabolite ratio, which was obtained from Table 10. The correlation coefficients for set one are 
11.259 a n d -0.003 with a p-value o f 0.271. The correlation coefficients for set two are 8.613 a n d -0 .0 0 2  
with a p-value o f 0.027.
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Figure 26. A linear fit o f the metabolite ratio P/GPE values for set one that consists o f 4, 6, 8, and 12 Gy 
doses, and set two consist o f 4.5, 5, 5.5, 6. and 8.5 Gy doses. An Error bar o f  1.71 percent was placed on 
the control metabolite ratio, which was obtained from Table 10. The correlation coefficients for set one are 
9.418 and -0 .0 0 4  with a p-value o f 0.002. The correlation coefficients for set two are 5.470 and -0 .0 0 2  
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Figure 27. A linear fit o f the metabolite ratio P,/GPC values for set one that consists of 4. 6, 8. and 12 Gy 
doses, and set two consist o f 4.5, 5, 5.5, 6, and 8.5 Gy doses. An Error bar o f 1.2 percent was placed on the 
control metabolite ratio, w hich was obtained from Table 10. The correlation coefficients for set one are 
7.562 and -0 .004  with a p-value o f  0.016. The correlation coefficients for set two are 3.332 and -0 .0 0 2  
with a p-value o f 0.014.
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Figure 28. A  linear fit o f  tire metabolite ratio Pi/HEPl values for set one that consists o f 4, 6. 8, and 12 Gy 
doses, and set two consist o f 4.5. 5. 5.5. 6, and 8.5 Gy doses. An Error bar of 1.37 percent was placed on 
die control metabolite ratio, which was obtained from Table 10. The correlation coefficients for set one are 
3.64 and 8.64 x lO ’ with a p-value o f  0.188. The correlation coefficients for set two are 3.50 and 4.56 with 
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Figure 29. A  linear fit o f the metabolite ratio P,/HEP2 values for set one that consists of 4. 6, 8. and 12 Gy 
doses, and set two consist o f 4.5, 5. 5.5, 6, and 8.5 Gy doses. An Error bar o f 1.6 percent was placed on the 
control metabolite ratio, which was obtained from Table 10. The correlation coefficients for set one are 
4.617 and 0.001 with a p-value o f  0.184. The correlation coefficients for set two are 4.146 and 6.477 x  10" ' 
with a p-value o f 0.403.
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It was also found that a direct correlation exists between the amount of irradiation 
delivered and the changes in metabolite intensities for the MCF-7 cell line. It can be seen 
quantitatively and qualitatively that a dose difference of 50 cGy can be detected in the 
relative metabolite ratios o f MCF-7 cell line extracts. The exact graphical determination 
of the effects of irradiation on specific metabolite ratios will need to be explored through 
a variety o f different dose experiments. These experiments will help define the dose- 
relationship and its spectral reproducibility for each particular metabolite found using this 
extraction procedure. Based on these preliminary results, it has been shown that NMR 
can be used to monitor the effects of radiation therapy and, potentially, can be used to 
model the changes that occur in metabolites post-irradiation.
4.0 Conclusion
The most notable achievement of this research project was the development o f a 
new procedure for cellular metabolite extraction. A number o f modifications were 
performed tliroughout the development o f the freeze-thaw extraction procedure. These 
changes optimized parameters such as cell handling techniques, temporal stability, and 
signal-to-noise ratio values. All o f these individual parameters, combined, optimized the 
overall reproducibility o f ' and spectra. This new method of extraction could lead to 
new insights into the changes that occur in cellular metabolite levels following treatment.
Additionally, an extensive reproducibility study was performed on the control 
samples. This particular type o f study has not been previously reported. The results from 
this study indicate that the reproducibility of intra-batch samples was much higher than 
that of inter-batch samples. The percent error values for intra-batch samples ranged from
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2.53 % to 7.98 % for all the different relative metabolite ratios, and for inter-batch 
samples, the values ranged from 38.61 % to 49.90 %.
Finally, the preliminary irradiation study in this project examined the effected 
delay time between irradiation and freeze-thaw extraction. The post-irradiation times of 
2, 24 and 48 h were chosen. The time of 48 h post-irradiation was determined to have the 
greatest quantitative change in spectra, and therefore, it was concluded to yield the 
highest sensitivity. As a result o f these findings, a range o f doses (4 to 12 Gy) was 
examined at 48 h post-irradiation. A qualitative examination of peak height ratios was 
performed for all of the phosphorous metabolites found in MCF-7 extracts. It was 
determined that a direct correlation exists between the amount o f irradiation delivered, 
and the changes in metabolite intensities for the MCF-7 cell line. Therefore, based on 
these preliminary results, it has been shown that ^^P NMR can be used to monitor the 
effects of radiation therapy and, potentially, to quantify- a dose-response relationship.
4.0 Future Work
There are a number o f modifications that could improve the reproducibility o f ^^P 
spectra for intra-batch and inter-batch samples. The simplest modification would be to 
monitor the confluency o f the cell culture dishes in order to ensure the same cell 
population for all samples. Another modification would be the implementation of cell 
synchronization. This process fixes the cells in a particular phase (M, Gi, G] or S) 
depending on the reagent chosen. Therefore, with a large percentage o f the cells (~ 80- 
90%) in one particular phase, the metabolite levels for all samples would be essentially 
fixed. Hence, samples run on the same day could potentially show improved
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reproducibility. More importantly, this process could have a greater effect on the 
reproducibility o f samples from different days.
Spectral reproducibility could be improved with a spin-lattice (Ti) relaxation time 
study. This study would examine variations in the Ti values for the metabolites detected 
in spectra of intra-batch and inter-batch samples. If T; values show differences, this 
would have a direct effect on the relative intensity o f each metabolite. Therefore, a 
modification that would resolve this problem could be implemented. This could be 
something as simple as a longer inter-pulse delay period (> 3 x longest T I) or the 
addition of a relaxation agent (fixed concentration), guaranteeing full relaxation of all the 
metabolite signals.
The last modification that could be made to improve reproducibility would be to 
use a different quantitative analysis method. The method of integration (peak area) would 
determine the relative total metabolite concentration. This new statistical analysis could 
correlate the changes found in each metabolite ratio. This would result in a 
characterization o f the system as a whole. Also, the use o f a Gaussian or Lorentzian curve 
fitting should be investigated.
Both integration and curve fitting will require an improvement in S/N. The use of 
filtration would reduce the cellular debris in samples and therefore, enhance the signal-to- 
noise ratio. The decrease in cellular debris would also allow for a higher concentration of 
cells per sample that would yield a higher S/N ratio. The reduction in cellular debris 
would also create more mobility for the cellular metabolites, which would reduce the 
broadening of the peaks in both  ̂̂ P and 'H  spectra. The reduction in broadening effects
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would largely improve spectra and therefore, the same method o f quantification used
for the metabolites in spectra would be used for spectra.
It is apparent, from the preliminary results in this project, that the standard 
deviations o f control samples may not be applicable for irradiation sample 
reproducibility. To provide standard deviations o f irradiated samples, reproducibility 
studies, similar to those previously performed for control samples, will be required. On 
the other hand, two control samples could be used for each irradiation experiment. In this 
experiment, one control would receive the maximum dose, and the other control would 
receive the minimum dose for the range used. The reproducibility o f irradiated runs 
would have to be tested because the determined control reproducibility may not apply to 
the reproducibility of irradiated samples at a specific dose.
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